May 31, 2020
Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
May 13, 2020
TYVYT® (Sintilimab Injection) ORIENT-2 Study Met its Primary Endpoint of Overall Survival in the Second-Line Treatment of Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
May 13, 2020
Sanofi to showcase oncology portfolio and innovative pipeline at ASCO20 Virtual Scientific Program
May 05, 2020
Libtayo® (cemiplimab) Shows Clinically-Meaningful and Durable Responses in Second-line Advanced Basal Cell Carcinoma
Apr 08, 2020
Sirnaomics Announces Positive Topline Results from Interim Analysis of Ongoing Phase II Clinical Trial Evaluating STP705 in Cutaneous Squamous Cell Carcinoma in situ (isSCC)
Mar 17, 2020
Grant Awarded to Fund Promising New Research into Enhancing Efficacy of Immunotherapy
Mar 09, 2020
Sirnaomics to Showcase Data for Lead Product STP705 in Human Squamous Carcinoma Tumor Model at 2020 American Academy of Dermatology Annual Meeting
Jan 08, 2020
CStone announces first patient dosed in the Phase III trial of CS1001 in combination with chemotherapy in first-line esophageal squamous cell carcinoma
Jan 07, 2020
3Derm announces two FDA Breakthrough Device designations for autonomous skin cancer AI
Dec 18, 2019
Investigator-initiated Phase II Clinical Study of Remetinostat Started in Patients With Squamous Cell Carcinoma
Dec 09, 2019
Publication of First In-Human Data Reveals Safety & Efficacy of Tigilanol Tiglate in Solid Tumours
Dec 03, 2019
QBiotics Announces First Patient Dosed in its Phase I/II Clinical Trial of Tigilanol Tiglate for Head and Neck Cancer
Sep 30, 2019
Rakuten Medical Releases New, Post-hoc Analysis of Safety, Pharmacokinetic (PK), Immunogenicity and Biomarker Data from its Phase 1 & 1/2a Clinical Trials
Sep 19, 2019
2019 CSCO | CStone announces promising trial data on its anti-PD-L1 antibody in esophageal squamous cell carcinoma with an ORR of 77.8%
May 15, 2019
Rakuten Medical Highlights Upcoming Presentations and Activities During the ASCO Annual Meeting, May 31 - June 4, 2019 in Chicago
Apr 01, 2019
Vaccibody AS and Nektar Therapeutics Present New Preclinical Data from their Immuno-Oncology Collaboration at the American Association for Cancer Research (AACR) Annual Meeting 2019
Feb 12, 2019
Cure Rate Exceeds 97 Percent in Retrospective Study of Sensus Healthcare's SRT-100(TM) for Treating Basal and Squamous Cell Carcinomas of the Lower Extremities
Jan 24, 2019
Cutaneous Squamous Cell Carcinoma (cSCC) Market Insights, Epidemiology and Market Forecasts, 2016-2018 & 2027
Jan 01, 2019
Innovent Announces First Patient Dosed in a Phase III Clinical Trial of Anti-PD-1 Antibody Tyvyt® (Sintilimab injection) as First-line Treatment for Patients with Advanced Esophageal Cancer
Sep 12, 2018
The Dark Side of the Hottest Summer in a Century: 'The High Rate of Skin Cancer Among Outdoor Workers can be Expected to Increase Still Further'